Joe Lennerz: Cover Story in Cancer Cell
Joe Lennerz, Chief Scientific Officer at BostonGene, shared on LinkedIn:
“Cover Story in Cancer Cell. Yay. Here, we (BostonGene) report a new platform for immunoprofiling using a simple blood test. This solution uses a combination of advanced laboratory techniques to comprehensively analyze the immune system of patients with cancer.
Traditional methods for assessing immune health have been limited and this platform aims to change that. By studying blood samples from both healthy people and cancer patients, we
identified five distinct patterns, or “immunotypes,” of immune activity (G1-G5).
These patterns are consistent across different types of cancer. Based on these immunotypes we developed a scoring system to measure these patterns, which can help to predict how patients might respond to various cancer treatments, including immunotherapy.
Ultimately, this simple blood can help doctors in tailoring treatments to individual patients based on their immune profiles.
Big high-five to the team entire team (sorry had to shorten because too many): Daniiar Dyikanov, Aleksandr Zaitsev, Tatiana Vasileva, Iris Wang, Arseniy Sokolov, Evgenii Bolshakov, Alena Frank, Polina Turova, Volha (Olga) Golubeva, Anna Gantseva, Anna Kamysheva, Polina Shpudeiko, Ilya Krauz, Mary Abdou, Tori Conroy, Nicholas Merriam, Julia Alesse, Noël English, Boris Shpak, Anna Shchetsova, Evgenii Tikhonov, Ivan Filatov, Anastasia Radko, Anastasia Bolshakova, Anastasiia Kachalova, Nika Lugovykh, Andrey Bulahov, Anastasiia Kilina, Syimyk Asanbekov, Linda Balabanian, Krystle Nomie, Sheila Yong, Christopher Davitt, Alexander Ryabykh, Olga Kudryashova, Cagdas Tazearslan, Alexander Bagaev, Nathan Fowler, Adam Luginbuhl, Ravshan Ataullakhanov, under the amazing leadership of Michael Goldberg.
Special props to Alfiia Mustafina, our fantastic science visualization specialist, who made the fantastic cover. .
Link to Publication.
Link to Cover.
DOI”
Source: Joe Lennerz/LinkedIn